Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Gut Brain Axis

Public_Health

Public Health Video Recap—March 13, 2026

Welcome to our biweekly public health video recap, summarizing the latest…

Public_Health

Public Health Today—March 13, 2026

This weekly public health update highlights recent research, data analyses and…

Public_Health

Public Health Today—February 20, 2026

This weekly Public Health update covers major research and population-health…

Public_Health

Public Health Weekly News - July 25th 2025

🔬 Public Health Updates: Hormone-free Male Birth Control Pill, Repurposed…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Neuroscience Today—March 25, 2026
Immunology Today—March 25, 2026
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Obesity Today—March 24, 2026
Endocrinology Today—March 24, 2026

Tags

ABX1100 Acute Ischaemic Stroke BBM-H803 Butantan-DV Chronic disease mortality conduction-system pacing cost reduction DIPS Arena Enzalutamide FDA Digital Health Advisory FG001 fragmentomics GentiBio GLP-1 Receptor Agonists gout flares Helmholtz Munich IMAAVY Jaypirca JUST-AAV Late-Onset Pompe Disease licensing Linerixibat live biotherapeutic product LUMEVOQ Metsera MicroRNAs Molgramostim Inhalation Solution naxtarubicin OCALIVA OpenGenome2 PPMS preclinical Rapport Therapeutics Rinvoq Rituximab Sensitive Skin Research Singapore Ministry Of Health Spikevax Stanford Medicine Sutra Medical SVT-001 Taldefgrobep Alfa TG Therapeutics Transgene Ver-A-T1D

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Neuroscience Today—March 25, 2026
Immunology Today—March 25, 2026
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Obesity Today—March 24, 2026
Endocrinology Today—March 24, 2026

TAGS

ABX1100 Acute Ischaemic Stroke BBM-H803 Butantan-DV Chronic disease mortality conduction-system pacing cost reduction DIPS Arena Enzalutamide FDA Digital Health Advisory FG001 fragmentomics GentiBio GLP-1 Receptor Agonists gout flares Helmholtz Munich IMAAVY Jaypirca JUST-AAV Late-Onset Pompe Disease licensing Linerixibat live biotherapeutic product LUMEVOQ Metsera MicroRNAs Molgramostim Inhalation Solution naxtarubicin OCALIVA OpenGenome2 PPMS preclinical Rapport Therapeutics Rinvoq Rituximab Sensitive Skin Research Singapore Ministry Of Health Spikevax Stanford Medicine Sutra Medical SVT-001 Taldefgrobep Alfa TG Therapeutics Transgene Ver-A-T1D

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy